An shRNA based screening method for TSC synthetic lethal screens
Awardee: Norbert Perrimon
Institution: Harvard Medical School
Award Amount: $50,500
Funding Period: January 1, 2016 - December 31, 2016
Previous
Previous
Mouse models of Fibrous Dysplasia (FD) as a tool for developing rational and effective therapies
Next
Next